These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10796738)

  • 21. Beta-sitosterols for benign prostatic hyperplasia.
    Wilt T; Ishani A; MacDonald R; Stark G; Mulrow C; Lau J
    Cochrane Database Syst Rev; 2000; 1999(2):CD001043. PubMed ID: 10796740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Terazosin for benign prostatic hyperplasia.
    Wilt TJ; Howe RW; Rutks IR; MacDonald R
    Cochrane Database Syst Rev; 2002; (4):CD003851. PubMed ID: 12519611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microwave thermotherapy for benign prostatic hyperplasia.
    Hoffman RM; Monga M; Elliott SP; Macdonald R; Langsjoen J; Tacklind J; Wilt TJ
    Cochrane Database Syst Rev; 2012 Sep; (9):CD004135. PubMed ID: 22972068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serenoa repens for benign prostatic hyperplasia.
    Wilt T; Ishani A; Stark G; MacDonald R; Mulrow C; Lau J
    Cochrane Database Syst Rev; 2000; (2):CD001423. PubMed ID: 10796790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidisciplinary approach to prostatitis.
    Magri V; Boltri M; Cai T; Colombo R; Cuzzocrea S; De Visschere P; Giuberti R; Granatieri CM; Latino MA; Larganà G; Leli C; Maierna G; Marchese V; Massa E; Matteelli A; Montanari E; Morgia G; Naber KG; Papadouli V; Perletti G; Rekleiti N; Russo GI; Sensini A; Stamatiou K; Trinchieri A; Wagenlehner FME
    Arch Ital Urol Androl; 2019 Jan; 90(4):227-248. PubMed ID: 30655633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification, pharmacologic considerations, and management of prostatitis.
    Schiller DS; Parikh A
    Am J Geriatr Pharmacother; 2011 Feb; 9(1):37-48. PubMed ID: 21459307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phytotherapy for benign prostatic hyperplasia.
    Wilt TJ; Ishani A; Rutks I; MacDonald R
    Public Health Nutr; 2000 Dec; 3(4A):459-72. PubMed ID: 11276294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.
    Mehik A; Alas P; Nickel JC; Sarpola A; Helström PJ
    Urology; 2003 Sep; 62(3):425-9. PubMed ID: 12946740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. WITHDRAWN: Cernilton for benign prostatic hyperplasia.
    Wilt TJ; Macdonald R; Ishani A; Rutks I; Stark G
    Cochrane Database Syst Rev; 2011 May; 2011(5):CD001042. PubMed ID: 21563128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacotherapy for hyperuricemia in hypertensive patients.
    Gois PH; Souza ER
    Cochrane Database Syst Rev; 2013 Jan; (1):CD008652. PubMed ID: 23440832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study.
    Schaeffer AJ; Knauss JS; Landis JR; Propert KJ; Alexander RB; Litwin MS; Nickel JC; O'Leary MP; Nadler RB; Pontari MA; Shoskes DA; Zeitlin SI; Fowler JE; Mazurick CA; Kusek JW; Nyberg LM;
    J Urol; 2002 Sep; 168(3):1048-53. PubMed ID: 12187220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.
    Nair B; Wilt T; MacDonald R; Rutks I
    Cochrane Database Syst Rev; 2002; (1):CD003506. PubMed ID: 11869665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary supplements for chronic gout.
    Andrés M; Sivera F; Falzon L; Buchbinder R; Carmona L
    Cochrane Database Syst Rev; 2014 Oct; (10):CD010156. PubMed ID: 25287939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WITHDRAWN: Terazosin for benign prostatic hyperplasia.
    Wilt TJ; Howe RW; Rutks I; Macdonald R
    Cochrane Database Syst Rev; 2011 Sep; 2011(9):CD003851. PubMed ID: 21901686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urate oxidase for the prevention and treatment of tumor lysis syndrome in children with cancer.
    Cheuk DK; Chiang AK; Chan GC; Ha SY
    Cochrane Database Syst Rev; 2010 Jun; (6):CD006945. PubMed ID: 20556770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome: a Cochrane systematic review.
    Franco JVA; Turk T; Jung JH; Xiao YT; Iakhno S; Tirapegui FI; Garrote V; Vietto V
    BJU Int; 2020 Apr; 125(4):490-496. PubMed ID: 31899937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis.
    Anothaisintawee T; Attia J; Nickel JC; Thammakraisorn S; Numthavaj P; McEvoy M; Thakkinstian A
    JAMA; 2011 Jan; 305(1):78-86. PubMed ID: 21205969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interventions for tophi in gout.
    Sriranganathan MK; Vinik O; Pardo Pardo J; Bombardier C; Edwards CJ
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD010069. PubMed ID: 34379791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review.
    Wilt TJ; Ishani A; Stark G; MacDonald R; Lau J; Mulrow C
    JAMA; 1998 Nov; 280(18):1604-9. PubMed ID: 9820264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Memantine for dementia.
    Areosa SA; Sherriff F
    Cochrane Database Syst Rev; 2003; (1):CD003154. PubMed ID: 12535459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.